These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26686875)

  • 1. The connection Between Plasma Protein Binding and Acute Toxicity as Determined by the LD50 Value.
    Svennebring A
    Drug Dev Res; 2016 Feb; 77(1):3-11. PubMed ID: 26686875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the prerequisites for the optimization of specific plasma protein binding as a strategy for the reduction of first-pass hepatic metabolism.
    Svennebring AM
    Xenobiotica; 2015 Apr; 45(4):286-301. PubMed ID: 25364858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure--plasma protein binding relationships of acidic drugs.
    Zhivkova Z; Doytchinova I
    J Pharm Sci; 2012 Dec; 101(12):4627-41. PubMed ID: 22961754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    Sui X; Sun J; Li H; Wang Y; Liu J; Liu X; Zhang W; Chen L; He Z
    Eur J Med Chem; 2009 Nov; 44(11):4455-60. PubMed ID: 19586686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
    Curran RE; Claxton CR; Hutchison L; Harradine PJ; Martin IJ; Littlewood P
    Drug Metab Dispos; 2011 Mar; 39(3):551-7. PubMed ID: 21098647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the concentration of drug binding plasma proteins on drug distribution according to Øie-Tozer's model.
    Svennebring AM
    Xenobiotica; 2016; 46(4):307-14. PubMed ID: 26259025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can acute dermal systemic toxicity tests be replaced with oral tests? A comparison of route-specific systemic toxicity and hazard classifications under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS).
    Moore NP; Andrew DJ; Bjerke DL; Creton S; Dreher D; Holmes T; Prieto P; Seidle T; Rowan TG
    Regul Toxicol Pharmacol; 2013 Jun; 66(1):30-7. PubMed ID: 23461858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of unbound drug concentration and protein-drug binding fraction in plasma.
    Liu Z; Li F; Huang Y
    Biomed Chromatogr; 1999 Jun; 13(4):262-6. PubMed ID: 10416057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ProTox: a web server for the in silico prediction of rodent oral toxicity.
    Drwal MN; Banerjee P; Dunkel M; Wettig MR; Preissner R
    Nucleic Acids Res; 2014 Jul; 42(Web Server issue):W53-8. PubMed ID: 24838562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compilation of 222 drugs' plasma protein binding data and guidance for study designs.
    Zhang F; Xue J; Shao J; Jia L
    Drug Discov Today; 2012 May; 17(9-10):475-85. PubMed ID: 22210121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins.
    Tillement JP; Albengres E; Urien S
    Eur J Drug Metab Pharmacokinet; 1979; 4(3):123-7. PubMed ID: 393513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of acute toxicity testing of pharmaceuticals for estimation of human response.
    Barle EL; Looser R; Cerne M; Bechter R
    Regul Toxicol Pharmacol; 2012 Apr; 62(3):412-8. PubMed ID: 22306828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and tissue binding considerations in drug disposition.
    Wilkinson GR
    Drug Metab Rev; 1983; 14(3):427-65. PubMed ID: 6347593
    [No Abstract]   [Full Text] [Related]  

  • 14. On the distribution of drugs in saliva and blood plasma.
    Feller K; le Petit G
    Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):468-9. PubMed ID: 21854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond size, ionization state, and lipophilicity: influence of molecular topology on absorption, distribution, metabolism, excretion, and toxicity for druglike compounds.
    Yang Y; Engkvist O; Llinàs A; Chen H
    J Med Chem; 2012 Apr; 55(8):3667-77. PubMed ID: 22443161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein binding: from discovery to development.
    Bohnert T; Gan LS
    J Pharm Sci; 2013 Sep; 102(9):2953-94. PubMed ID: 23798314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of low temperature on fraction unbound for plasma and tissue.
    Ryu S; Novak JJ; Patel R; Yates P; Di L
    Biopharm Drug Dispos; 2018 Nov; 39(9):437-442. PubMed ID: 30362129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure.
    Leach AG; Jones HD; Cosgrove DA; Kenny PW; Ruston L; MacFaul P; Wood JM; Colclough N; Law B
    J Med Chem; 2006 Nov; 49(23):6672-82. PubMed ID: 17154498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds.
    Yamazaki K; Kanaoka M
    J Pharm Sci; 2004 Jun; 93(6):1480-94. PubMed ID: 15124206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodialysis.
    Keller F; Wilms H; Schultze G; Offerman G; Molzahn M
    Clin Nephrol; 1983 Apr; 19(4):201-5. PubMed ID: 6851257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.